Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Insmed Incorporated (INSM) News - StockMarketCap

Stocks›Insmed Incorporated☆

● At closeAs of Jul 2, 2026

Insmed Incorporated

INSM✓

HealthcareBiotechnologyNASDAQ

$111.60+4.30%

$24.19BMarket cap

-18.54xP/E ratio

2.75MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$111.60

$4.60 (+4.30%) · 24h

Key metrics

Market cap$24.19B+0.56%

Enterprise value$23.28B

Volume (24h)2.75M

P/E ratio (TTM)-18.54x

P/S ratio (TTM)28.20x

Dividend yield0.00%

Shares outstanding216.75M

Trading range

Previous close$107.00

Day range$107.06 - $111.79

52-week range$90.39 - $212.75

Insmed Incorporated (INSM) operates in the Biotechnology industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news